Lunai Bioworks Inc.
LNAI
$2.33
$0.041.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -49.15% | -44.40% | -30.50% | -27.19% | -16.14% |
| Depreciation & Amortization | -24.45% | -6.75% | 8.82% | 5.91% | 7.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.43% | -48.68% | -36.85% | -32.28% | -23.18% |
| Operating Income | 50.54% | 48.68% | 36.85% | 32.28% | 23.18% |
| Income Before Tax | -91.45% | 0.53% | -6.09% | -101.31% | 30.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -91.45% | 0.53% | -6.09% | -101.31% | 30.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.45% | 0.53% | -6.09% | -101.31% | 30.12% |
| EBIT | 50.54% | 48.68% | 36.85% | 32.28% | 23.18% |
| EBITDA | 50.73% | 48.89% | 37.09% | 32.45% | 23.32% |
| EPS Basic | -70.87% | 26.09% | 24.12% | -21.54% | 63.03% |
| Normalized Basic EPS | 63.99% | 63.85% | 61.26% | 65.70% | 61.75% |
| EPS Diluted | -70.55% | 26.15% | 24.18% | -21.42% | 62.96% |
| Normalized Diluted EPS | 63.92% | 63.99% | 61.37% | 65.78% | 61.82% |
| Average Basic Shares Outstanding | 39.55% | 37.23% | 49.31% | 69.14% | 113.01% |
| Average Diluted Shares Outstanding | 39.21% | 37.50% | 49.64% | 69.55% | 113.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |